
生物标志物指导的ABC-AF风险评分:评估其在房颤个性化治疗中的作用
一项大型随机研究发现,基于生物标志物的ABC-AF风险评分指导的治疗并未改善房颤患者的卒中或死亡结局,这突显了在临床采用前对精准医疗工具进行严格前瞻性验证的必要性。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.